UCSF at Berkeley Outpatient Center, Berkeley
Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
UCSD Medical Center - Encinitas, Encinitas
a 21 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

DESTINY-PANTUMOUR04

Research Site, San Diego

Prebieha náborObservačná štúdia

Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

UC San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
UCLA Hematology/Oncology- Santa Monica, Los Angeles

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Stanford Cancer Center, Palo Alto

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT05274048

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

University of California, San Francisco, San Francisco

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06633224

Personalized Health Self-Management Training for Colorectal Cancer Survivors

University of Southern California, Los Angeles

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT05984589

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

University of Southern California, Los Angeles
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
Cedars-Sanai Medical Center, Los Angeles
a 1 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06582017

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

Kaiser Permanente Northern California, Pleasanton

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07776353

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

University of California, San Francisco, San Francisco
John Muir Medical Center-Walnut Creek, Walnut Creek

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT04221893

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

GSK Investigational Site, Los Alamitos
GSK Investigational Site, Los Angeles
GSK Investigational Site, Santa Monica
a 1 ďalších

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06885034

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

USC Norris Comprehensive Cancer Center, Los Angeles

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07337525

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

City of Hope Nat Medical Ctr, Duarte

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07224750

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

University of California, Davis Comprehensive Cancer Center, Sacramento

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

St Joseph Heritage Healthcare, Santa Rosa

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 27. 5. 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

UC Irvine/Chao Family Comprehensive Cancer Center, Orange
UCLA, Santa Monica

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Cedars-Sinai Medical Center, Los Angeles

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 4. 2026 · NCT07020221

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Interventional Endoscopy Services, San Francisco

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 3. 2026 · NCT01750619

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Prebieha náborSkorá fáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 2. 2026 · NCT06511037

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Cedars-Sinai Medical Center, Los Angeles

Prebieha nábor

Vek 18 až 99 · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT04907643

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

Cedars-Sinai Medical Center, Los Angeles

Prebieha náborFáza 4

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2025 · NCT07124351

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

City Of Hope, Duarte
Stanford Cancer Center, Palo Alto

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 15. 8. 2025 · NCT05406167

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models

City of Hope, Duarte

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2023 · NCT06002425

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.